RE:RE:RE:Seriously? 3:1A reverse split with a clear path to uplist to a senior exchange is not a bad idea.
If Roger can raise several million at 30 cents then well done. If he's raising another 500K that's another story.
He would be better off raising more money for a lower price than less money at a higher one. The longer he drags out getting patients treated, the longer to market.
The great thing is that we will know soon.
His stated goal is to complete 100 patients by end of 2024. One, this costs money. Two, operating timeslots need to be available. These clinics aren't going to book / screen patients if they aren't paid.
My guess (just a guess) is that we are still at 75 patients. This is why they've opened the door to Q1. And why Roger hinted 85 patients might be good. I suspect they are asking thr FDA if stopping at say, 78, is acceptable. It's about money.
I hope to be able to buy back in. Theralase is a compelling story. But yes, it's not a perfect story.